SCHEMBL29475652

SCHEMBL29475652

CCCCOc1nc(N)c2[nH]c(=O)n(Cc3ccc(CN4CCC(CCNC(=O)C(C)(C)C)CC4)cc3)c2n1

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 20/20 0.65
▸ IL6 P05231 10/20 0.65
▸ TLR8 Q9NR97 4/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22347092 1.00 TLR7 (0.65) TLR7IL6TLR8
SCHEMBL22359234 0.94 TLR7 (0.61) TLR7IL6TLR8
SCHEMBL28663619 0.93 TLR7 (0.65) TLR7IL6TLR8
SCHEMBL22359263 0.93 TLR7 (0.65) TLR7IL6TLR8
SCHEMBL26354074 0.92 TLR7 (0.66) TLR7IL6TLR8
SCHEMBL26347760 0.91 TLR7 (0.63) TLR7IL6TLR8
SCHEMBL22347067 0.91 TLR7 (0.62) TLR7IL6TLR8
SCHEMBL26347740 0.91 TLR7 (0.62) TLR7IL6TLR8
SCHEMBL26347721 0.91 TLR7 (0.64) TLR7IL6TLR8
SCHEMBL26347747 0.90 TLR7 (0.57) TLR7IL6TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119455003-A Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2025-02-18 — — CN disclosed
CN-119455004-A Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2025-02-18 — — CN disclosed
CN-113660957-B Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2024-12-13 — — CN disclosed
EP-4199968-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF Ambrx, Inc. (US) 2023-06-28 — — EP disclosed
WO-2022040596-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF AMBRX, INC. (US) 2022-02-24 — — WO disclosed
Send feedback